Giltuss Cough And Cold Solution
NDC Package 65852-012-04
Package Information
Giltuss Cough And Cold (dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride) solution is directions, do not exceed recommended dosage, do not take more than 6 doses in any 24 hours period, keep dosing cup for use with this product, ml=mililiters.Adults and children 12 years & over 5 ml every 4 hourschildren 6 to under 12 years age 2.5 ml every 4 hourschildren 4 to 6 years of age 1.25 ml every 4 hourschildren under 6 years of age Consult a doctor. This formulation utilizes a solution delivery system. Marketed by Dextrum Laboratories Inc., this product is identified by NDC 65852-012 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1251031 - dextromethorphan HBr 15 MG / guaiFENesin 300 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution
- RxCUI: 1251031 - dextromethorphan hydrobromide 3 MG/ML / guaifenesin 60 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution
- RxCUI: 1251031 - dextromethorphan HBr 15 MG / guaifenesin 300 MG / phenylephrine HCl 10 MG per 5 ML Oral Solution
Clinical Specifications
- Adrenergic alpha1-Agonists - [MoA] (Mechanism of Action)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
- alpha-1 Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 65852 - Dextrum Laboratories Inc.
- 65852-012 - Giltuss Cough And Cold
- 65852-012-04 - 1 BOTTLE, PLASTIC in 1 CARTON / 113 mL in 1 BOTTLE, PLASTIC
- 65852-012 - Giltuss Cough And Cold
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65852-012-04 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 113 ml in 1 bottle, plastic of Giltuss Cough And Cold, a human over the counter drug labeled by Dextrum Laboratories Inc.. This solution is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin; phenylephrine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dextrum Laboratories Inc. on October 02, 2018. The current certification is valid through December 31, 2026.
How is this Dextrum Laboratories Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65852001204. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.